Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.

Tagliabue, E; Ardini, E; Pellegrini, R; Campiglio, M; Bufalino, R; Jeschke, M; Groner, B; Colnaghi, M I; Ménard, S

Tagliabue, E; Ardini, E; Pellegrini, R; Campiglio, M; Bufalino, R; Jeschke, M; Groner, B; Colnaghi, M I; Ménard, S.

Affiliation

Tagliabue E; Division of Experimental Oncology E, Istituto Nazionale Tumori, Milan, Italy.

Br J Cancer ; 74(9): 1427-33, 1996 Nov.

Article in En | MEDLINE | ID: mdl-8912540

Subject(s)

Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Laminin/biosynthesis; Laminin/pharmacology; Neoplasm Proteins/drug effects; Receptor, ErbB-2/drug effects; Cell Division/drug effects; Down-Regulation; Female; Fibronectins/pharmacology; Genes, erbB-2; Humans; Neoplasm Proteins/metabolism; Phosphorylation; Receptor, ErbB-2/metabolism; Tumor Cells, Cultured; Tyrosine/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Laminin / Receptor, ErbB-2 / Neoplasm Proteins Limits: Female / Humans Language: En Journal: Br J Cancer Year: 1996 Document type: Article

Fulltext

XML

PubMed Links

Search on Google